Orchid Pharma Limited

NSE ORCHPHARMA.NS

Orchid Pharma Limited Price to Earnings Ratio (P/E) on January 14, 2025: 84.42

Orchid Pharma Limited Price to Earnings Ratio (P/E) is 84.42 on January 14, 2025, a 6.16% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Orchid Pharma Limited 52-week high Price to Earnings Ratio (P/E) is 134.26 on February 26, 2024, which is 59.03% above the current Price to Earnings Ratio (P/E).
  • Orchid Pharma Limited 52-week low Price to Earnings Ratio (P/E) is 52.63 on June 04, 2024, which is -37.66% below the current Price to Earnings Ratio (P/E).
  • Orchid Pharma Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is 80.39.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
NSE: ORCHPHARMA.NS

Orchid Pharma Limited

CEO Mr. Rajnish Rohatgi B. Tech.
IPO Date July 1, 2002
Location India
Headquarters Orchid Towers
Employees 871
Sector Health Care
Industries
Description

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company's multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. In addition, the company provides liaising support to customers in regulatory, pharma covigilance, testing and release, retention of samples, service providers, and business development. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited is a subsidiary of Dhanuka Laboratories Limited.

Similar companies

SOLARA.NS

Solara Active Pharma Sciences Limited

USD 7.64

4.37%

JUBLPHARMA.NS

Jubilant Pharmova Limited

USD 11.12

4.25%

PANACEABIO.NS

Panacea Biotec Limited

USD 4.79

-1.13%

GLAND.NS

Gland Pharma Limited

USD 19.28

-1.41%

StockViz Staff

January 15, 2025

Any question? Send us an email